ES2093037T3 - Derivados de beta-lactama y su preparacion. - Google Patents

Derivados de beta-lactama y su preparacion.

Info

Publication number
ES2093037T3
ES2093037T3 ES91102101T ES91102101T ES2093037T3 ES 2093037 T3 ES2093037 T3 ES 2093037T3 ES 91102101 T ES91102101 T ES 91102101T ES 91102101 T ES91102101 T ES 91102101T ES 2093037 T3 ES2093037 T3 ES 2093037T3
Authority
ES
Spain
Prior art keywords
lactama
beta
derivatives
preparation
presented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91102101T
Other languages
English (en)
Inventor
Makoto Sunagawa
Akira Sasaki
Hiroshi Yamaga
Masatomo Fukasawa
Hiroshi Nouda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Application granted granted Critical
Publication of ES2093037T3 publication Critical patent/ES2093037T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65H—HANDLING THIN OR FILAMENTARY MATERIAL, e.g. SHEETS, WEBS, CABLES
    • B65H2301/00—Handling processes for sheets or webs
    • B65H2301/50—Auxiliary process performed during handling process
    • B65H2301/51—Modifying a characteristic of handled material
    • B65H2301/514—Modifying physical properties
    • B65H2301/5142—Moistening
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE PRESENTA UN COMPUESTO DE LA FORMULA: EL CUAL ES UTIL COMO AGENTE ANTIMICROBIANO.
ES91102101T 1990-02-14 1991-02-14 Derivados de beta-lactama y su preparacion. Expired - Lifetime ES2093037T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3495290 1990-02-14

Publications (1)

Publication Number Publication Date
ES2093037T3 true ES2093037T3 (es) 1996-12-16

Family

ID=12428500

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91102101T Expired - Lifetime ES2093037T3 (es) 1990-02-14 1991-02-14 Derivados de beta-lactama y su preparacion.

Country Status (6)

Country Link
EP (1) EP0442497B1 (es)
KR (1) KR0173987B1 (es)
AT (1) ATE141272T1 (es)
CA (1) CA2036163C (es)
DE (1) DE69121259T2 (es)
ES (1) ES2093037T3 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
RU2093514C1 (ru) * 1991-06-04 1997-10-20 Санкио Компани Лимитед Производные 1-метилкарбапенема и способ их получения
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
JP3091297B2 (ja) * 1992-01-10 2000-09-25 住友製薬株式会社 ピロリジン誘導体およびその製造方法
FI103046B1 (fi) * 1992-03-11 1999-04-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrrolidinyylitiokarbapeneemijohdannaisten valmistamiseksi
EP0581501B1 (en) * 1992-07-21 1998-09-09 Zeneca Limited Antibiotic carbapenem compounds
CA2099811A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
AU4912393A (en) * 1993-06-15 1994-12-22 Dong Kook Pharmaceutical Co., Ltd. 1-beta-methyl-2-thiolic carbapenem derivatives
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
AU4020897A (en) 1996-08-17 1998-03-06 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
TWI250160B (en) * 1999-07-06 2006-03-01 Sankyo Co Crystalline 1-methylcarbapenem compound
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
EP1449841A1 (en) * 2003-02-19 2004-08-25 Bayer CropScience SA New fungicidal compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
EP0182213B1 (en) * 1984-11-08 1990-09-26 Sumitomo Pharmaceuticals Company, Limited Carbapenem compounds and production thereof
EP0243686B1 (en) * 1986-03-27 1992-07-15 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production
NZ219892A (en) * 1986-04-15 1991-02-26 Merck & Co Inc N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
DE69121259D1 (de) 1996-09-19
KR910015582A (ko) 1991-09-30
ATE141272T1 (de) 1996-08-15
CA2036163C (en) 2001-06-19
EP0442497B1 (en) 1996-08-14
CA2036163A1 (en) 1991-08-15
KR0173987B1 (ko) 1999-02-01
DE69121259T2 (de) 1997-01-09
EP0442497A1 (en) 1991-08-21

Similar Documents

Publication Publication Date Title
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
ES2080739T3 (es) Nitro-compuestos insecticidamente activos.
PT1109812E (pt) Pirrolobenzodiazepinas
ES2085876T3 (es) Derivado de bifenilmetano, su utilizacion y composiciones farmacologicas que contienen el mismo.
ES2195970T3 (es) L-ribavirina y usos de la misma.
BG28556A3 (bg) Фунгицидно средство
ES2176698T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
DK506587A (da) Imidderivater
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
MA24028A1 (fr) Pesticides
ES2055867T3 (es) Derivados de dibenzotiazepina utiles como agentes antiespasmodicos.
ES462103A1 (es) Procedimiento para la preparacion del derivado yodurado de cloruro de benzalconio.
ES2097423T3 (es) Analogos de vitamina d3.
DE69128630D1 (de) Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält
GT199900064A (es) Derivados de higromicina a.
DE69936052D1 (de) N1 modifizierte glycopeptide
ES2053765T3 (es) Derivados antibacterianos de 9-desoxo-9a-alilo y propargil-9a-aza-9a-homoeritromicina a.
ATE296623T1 (de) Prolaktin-senkendes mittel
ES2059396T3 (es) Derivados de indeno y metodos.
ES2085051T3 (es) Usos de 1,1,1,3,3,3-hexafluoropropano.
EP0285983A3 (de) Mittel gegen Kleidermotten
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
FR2389624A1 (es)
PT713702E (pt) Agente ansiolitico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 442497

Country of ref document: ES